Early stages of bipolar disorder: Characterization and strategies for early intervention

Revista Brasileira de Psiquiatria

Volumn 37, Issue 4, 2015, Pages 343-349

  Rios, Adiel C ^a   Noto, Mariane N ^a   Rizzo, Lucas B ^a,b   Mansur, Rodrigo ^a,b   Martins, Flávio E ^a   Grassi Oliveira, Rodrigo ^c   Correll, Christoph U ^d,e,f,g   Brietzke, Elisa ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d ZUCKER HILLSIDE HOSPITAL   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^g DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

Bipolar disorder; Depression; Early intervention; First episode of mania; Manic depressive illness; Staging

Indexed keywords

ARTICLE; BIPOLAR DISORDER; CLINICAL PRACTICE; COGNITIVE THERAPY; DSM-III; DSM-IV; EARLY INTERVENTION; FOLLOW UP; FUNCTIONAL DISEASE; HOSPITALIZATION; HUMAN; HYPERACTIVITY; MAJOR DEPRESSION; QUALITY OF LIFE; RECURRENCE RISK; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; DISEASE COURSE; FEMALE; MALE; PATHOLOGY; PROCEDURES; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

BIPOLAR DISORDER; DISEASE PROGRESSION; EARLY MEDICAL INTERVENTION; FEMALE; HUMANS; MALE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84951103627     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/1516-4446-2014-1620     Document Type: Article

References (50)

1. Anderson IM, Haddad PM, Scott J. Bipolar disorder. BMJ. 2012;345: e8508-e8508.
2. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs. late-stage bipolar disorder. Int J Neuropsychopharmacol. 2009;12:447-58.
3. Gama CS, Kunz M, Magalhães PV, Kapczinski F. Staging and neuroprogression in bipolar disorder: a systematic review of the literature. Rev Bras Psiquiatr. 2013;35:70-4.
4. Rybakowski JK. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge. CNS Drugs. 2013;27:165-73.
5. Reinares M, Colom F, Rosa AR, Bonnín CM, Franco C, Solé B, et al. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord. 2010;123:81-6.
6. Berk M, Brnabic A, Dodd S, Kelin K, Tohen M, Malhi GS, et al. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 2011;13:87-98.
7. Conus P, Cotton S, Abdel-Baki A, Lambert M, Berk M, McGorry PD. Symptomatic and functional outcome 12 months after a first episode of psychotic mania: barriers to recovery in a catchment area sample. Bipolar Disord. 2006;8:221-31.
8. Gazalle FK, Andreazza AC, Kauer-Sant'Anna M, Santin A, Kapczinski F. [Early diagnosis of bipolar disorder]. Rev Bras Psiquiatr. 2005;27:83-4.
9. Vieta E, Reinares M, Rosa AR. Staging bipolar disorder. Neurotox Res. 2011;19:279-85.
10. Torrent C, Martinez-Arán A, del Mar Bonnin C, Reinares M, Daban C, Solé B, et al. Long-term outcome of cognitive impairment in bipolar disorder. J Clin Psychiatry. 2012;73:e899-905.
11. Reinares M, Colom F, Rosa AR, Bonnín CM, Franco C, Solé B, et al. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord. 2010;123:81-6.
12. Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry. 2006;188:313-20.
13. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011;35:804-17.
14. Fries GR, Pfaffenseller B, Stertz L, Paz AV, Dargél AA, Kunz M, et al. Staging and neuroprogression in bipolar disorder. Curr Psychiatry Rep. 2012;14:667-75.
15. Mansur RB, Cha DS, Asevedo E, McIntyre RS, Brietzke E. Selfish brain and neuroprogression in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2013;43:66-71.
16. Kapczinski F, Dias VV, Kauer-Sant'Anna M, Brietzke E, Vázquez GH, Vieta E, et al. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:1366-71.
17. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40:616-22.
18. Berk M, Hallam K, Lucas N, Hasty M, McNeil CA, Conus P, et al. Early intervention in bipolar disorders: opportunities and pitfalls. Med J Aust. 2007;187:S11-4.
19. McGorry PD. Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry. 2007;164:859-60.
20. Scott J, Leboyer M, Hickie I, Berk M, Kapczinski F, Frank E, Kupfer D, McGorry P. Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry. 2013;202:243-5.
21. Bauer M, Juckel G, Correll CU, Leopold K, Pfennig A. Diagnosis and treatment in the early illness phase of bipolar disorders. Eur Arch Psychiatry Clin Neurosci. 2008;258:50-4.
22. Bechdolf A, Nelson B, Cotton SM, Chanen A, Thompson A, Kettle J, et al. A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults. J Affect Disord. 2010;127:316-20.
23. Birmaher B, Axelson D, Goldstein B, Strober M, Gill MK, Hunt J, et al. Four year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry. 2009;166:795-804.
24. McNamara RK, Strawn JR, Chang KD, DelBello MP. Interventions for youth at high risk for bipolar disorder and schizophrenia. Child Adolesc Psychiatr Clin N Am. 2012;21:739-51.
25. Hauser M, Correll CU. The significance of at-risk or prodromal symptoms for bipolar I disorder in children and adolescents. Can J Psychiatry. 2013;58:22-31.
26. Bechdolf A, Ratheesh A, Cotton SM, Nelson B, Chanen AM, Betts J, et al. The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study. Bipolar Disord. 2014;16:493-504.
27. McMurrich S, Sylvia LG, Dupuy JM, Peckham AD, Peters AT, Deckersbach T, et al. Course, outcomes, and psychosocial interventions for first-episode mania. Bipolar Disord. 2012;14:797-808.
28. Tohen M, Waternaux CM, Tsuang MT, Hunt AT. Four-year follow-up of twenty-four first-episode manic patients. J Affect Disord. 1990;19:79-86.
29. Deckersbach T, Peters AT, Sylvia L, Urdahl A, Magalhães PVS, Otto MW, et al. Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD. Am J Psychiatry. 2014;171:178-86.
30. Tohen M, Stoll AL, Strakowski SM, Faedda GL, Mayer P V, Goodwin DC, et al. The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome. Schizophr Bull. 1992;18:273-82.
31. Tohen M, Zarate CA Jr, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry. 2003;160:2099-107.
32. Strakowski SM, Keck PE Jr, McElroy SL, West SA, Sax KW, Hawkins JM, et al. Twelve-month outcome after a first hospitalization for affective psychosis. Arch Gen Psychiatry. 1998;55:49-55.
33. Hamshere ML, Gordon-Smith K, Forty L, Jones L, Caesar S, Fraser C, et al. Age-at-onset in bipolar-I disorder: mixture analysis of 1369 cases identifies three distinct clinical sub-groups. J Affect Disord. 2009;116:23-9.
34. Perlis RH, Miyahara S, Marangell LB, Wisniewski SR, Ostacher M, DelBello MP, et al. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2004;55:875-81.
35. Daruy-Filho L, Brietzke E, Lafer B, Grassi-Oliveira R. Childhood maltreatment and clinical outcomes of bipolar disorder. Acta Psychiatr Scand. 2011;124:427-34.
36. Bücker J, Kapczinski F, Post R, Ceresér KM, Szobot C, Yatham LN, Kapczinski NS, Kauer-Sant'Anna M. Cognitive impairment in schoolaged children with early trauma. Compr Psychiatry. 2012;53:758-64.
37. Kim JS, Baek JH, Choi JS, Lee D, Kwon JS, Hong KS. Diagnostic stability of first-episode psychosis and predictors of diagnostic shift from non-affective psychosis to bipolar disorder: a retrospective evaluation after recurrence. Psychiatry Res. 2011;188:29-33.
38. Tohen M, Khalsa HM, Salvatore P, Vieta E, Ravichandran C, Baldessarini RJ. Two-year outcomes in first-episode psychotic depression the McLean-Harvard First-Episode Project. J Affect Disord. 2012;136: 1-8.
39. Tohen M, Hennen J, Zarate CM Jr, Baldessarini RJ, Strakowski SM, Stoll AL, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry. 2000;157:220-8.
40. Michalak EE, Torres IJ, Bond DJ, Lam RW, Yatham LN. The relationship between clinical outcomes and quality of life in first-episode mania: a longitudinal analysis. Bipolar Disord. 2013;15:188-98.
41. Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, Sanchez-Toledo JP, Zarate CA Jr, et al. McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry. 2009;70:458-66.
42. Vieta E, Pacchiarotti I, Valentí M, Berk L, Scott J, Colom F. A critical update on psychological interventions for bipolar disorders. Curr Psychiatry Rep. 2009;11:494-502.
43. Nadkarni RB, Fristad MA. Clinical course of children with a depressive spectrum disorder and transient manic symptoms. Bipolar Disord. 2010;12:494-503.
44. Jones SH, Burrell-Hodgson G. Cognitive-behavioural treatment of first diagnosis bipolar disorder. Clin Psychol Psychother. 2008;15:367-77.
45. Geller B, Cooper TB, Zimerman B, Frazier J, Williams M, Heath J, et al. Lithium for prepubertal depressed children with family history predictors of future bipolarity: a double-blind, placebo-controlled study. J Affect Disord. 1998;51:165-75.
46. Kowatch RA, Suppes T, Carmody TJ, Bucci JP, Hume JH, Kromelis M, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2000;39:713-20.
47. Chang KD, Dienes K, Blasey C, Adleman N, Ketter T, Steiner H. Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms. J Clin Psychiatry. 2003;64:936-42.
48. Findling RL, Frazier TW, Youngstrom EA, McNamara NK, Stansbrey RJ, Gracious BL, et al. Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder. J Clin Psychiatry. 2007;68:781-8.
49. DelBello MP, Adler CM, Whitsel RM, Stanford KE, Strakowski SM. A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder. J Clin Psychiatry. 2007;68:789-95.
50. Yatham LN, Kauer-Sant'Anna M, Bond DJ, Lam RW, Torres I. Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program For Early Mania project. Can J Psychiatry. 2009;54:105-12.